Analysis of Inadequacies in Hospital Care through Medical Liability Litigation.
claims
clinical inappropriateness
compensation
health care litigation
medical liability
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
25 03 2021
25 03 2021
Historique:
received:
22
02
2021
revised:
22
03
2021
accepted:
22
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
28
4
2021
Statut:
epublish
Résumé
Over the past two decades, health litigation has followed an exponentially incremental trend. As insurance companies tend to limit their interest because of the high risk of loss, health facilities increasingly need to internalize dispute management. This study was conducted through a retrospective analysis of existing files concerning the civil litigation of the Sant'Andrea Hospital in Rome. All claims from 1 June 2010 to 30 June 2019 were included. Paid claims were further classified according to the areas of health care inappropriateness found. Authors indexed 567 different claims along the study period, with an average number of 59 per year (range 38-77). The total litigation involved 47 different units; more than 40% concerned 5 high-incidence wards or services. Concerning the course of disputes, 91 cases were liquidated before a judicial procedure was instituted, while 177 cases landed in a civil court. Globally, 131 different claims hesitated in compensation, for a total of 16 million 625 thousand euros, 41% of which was related to the internal medicine area. Dealing with the inappropriateness analysis, clinical performance alone involved 76 cases, for a total of 10 million 320 thousand euros, while organization defects involved 20 disputes equivalent to 1 million 788 thousand euros. The aim of this study was to enhance the clinical risk management at our facility through a litigation analysis.
Identifiants
pubmed: 33806174
pii: ijerph18073425
doi: 10.3390/ijerph18073425
pmc: PMC8037280
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Environ Res Public Health. 2020 Oct 31;17(21):
pubmed: 33142740
Ann Ig. 2019 Sep-Oct;31(5):496-506
pubmed: 31304529
Glob Health Action. 2018;11(1):1458938
pubmed: 29658393
Curr Pharm Biotechnol. 2017;18(3):274-281
pubmed: 28176638
Ann Med Health Sci Res. 2016 Mar-Apr;6(2):74-9
pubmed: 27213088
BMC Health Serv Res. 2019 Feb 1;19(1):85
pubmed: 30709359
Jt Comm J Qual Patient Saf. 2014 Nov;40(11):484-12
pubmed: 26111366
J Manag Med. 1996;10(3):39-48
pubmed: 10162933
Risk Manag Healthc Policy. 2020 Mar 10;13:183-189
pubmed: 32210649
JAMA. 2011 Jun 15;305(23):2427-31
pubmed: 21673294
J Educ Health Promot. 2014 May 03;3:28
pubmed: 25013821
Jt Comm Perspect. 2007 Dec;27(12):1, 3
pubmed: 18257444
Int J Health Care Qual Assur. 2008;21(1):60-74
pubmed: 18437939
J Patient Saf. 2020 Dec;16(4):e299-e302
pubmed: 32941344
N Engl J Med. 2006 May 11;354(19):2024-33
pubmed: 16687715
Curr Pharm Biotechnol. 2019;20(8):625-634
pubmed: 30961487
JAMA. 1994 Dec 21;272(23):1851-7
pubmed: 7503827
Int J Environ Res Public Health. 2020 Oct 30;17(21):
pubmed: 33143348
Health Serv Res. 2016 Dec;51 Suppl 3:2642-2648
pubmed: 27892620
Curr Pharm Biotechnol. 2019;20(8):643-652
pubmed: 30961489
Med Leg J. 2020 Jul;88(2):90-97
pubmed: 32490743
Curr Pharm Biotechnol. 2019;20(8):653-657
pubmed: 30961488
Med Leg J. 2020 Nov;88(1_suppl):35-37
pubmed: 32519568
BMC Health Serv Res. 2015 Apr 01;15:130
pubmed: 25889588
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000259
pubmed: 22696318
Healthc Financ Manage. 2002 May;56(5):50-5
pubmed: 12013641
Curr Pharm Biotechnol. 2019;20(8):615-624
pubmed: 30961486
BMJ. 2017 May 22;357:j2277
pubmed: 28533264
Health Serv Manage Res. 2010 Feb;23(1):5-11
pubmed: 20150604
PLoS One. 2016 Apr 14;11(4):e0153362
pubmed: 27077661